Acute Promyelocytic Leukemia

Acute Promyelocytic Leukemia is the indication for 5 drugs in DrugBank. It is covered by 6 curated, structured indications.

Also known as: Acute Promyelocytic Leukemia (APL)
Classified under: Hemic and Lymphatic Diseases
Neoplasms
Indicated drugs: Arsenic trioxide
Cytarabine
Mercaptopurine
Methotrexate
Mitoxantrone

Resolves to

Vocabularies

MeSHT811701ICD-10C92.4SNOMED CT110004001MedDRA10001019UMLSC0023487

What you can answer from here — as of October 25, 2026

5Indicated drugsWith each drug's targets and mechanism

Listed above

6Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

77Clinical trialsPhase, status and sponsor resolved per trial

2Boxed warningsLabel boxed warnings that name this condition

3Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Acute Promyelocytic Leukemia share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.